HK127793A - Lithium salt-containing pharmaceutical compositions - Google Patents
Lithium salt-containing pharmaceutical compositionsInfo
- Publication number
- HK127793A HK127793A HK1277/93A HK127793A HK127793A HK 127793 A HK127793 A HK 127793A HK 1277/93 A HK1277/93 A HK 1277/93A HK 127793 A HK127793 A HK 127793A HK 127793 A HK127793 A HK 127793A
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical compositions
- lithium salt
- containing pharmaceutical
- lithium
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/06—Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Birds (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Addiction (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Virology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878709892A GB8709892D0 (en) | 1987-04-27 | 1987-04-27 | Virucidal compositions |
GB878719988A GB8719988D0 (en) | 1987-08-25 | 1987-08-25 | Chemical compounds |
GB888802016A GB8802016D0 (en) | 1987-04-27 | 1988-01-29 | Chemical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
HK127793A true HK127793A (en) | 1993-11-26 |
Family
ID=27263407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK1277/93A HK127793A (en) | 1987-04-27 | 1993-11-18 | Lithium salt-containing pharmaceutical compositions |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0289204B1 (xx) |
JP (1) | JP2699083B2 (xx) |
AU (1) | AU618730B2 (xx) |
CA (1) | CA1306944C (xx) |
DE (1) | DE3863678D1 (xx) |
DK (1) | DK173068B1 (xx) |
ES (1) | ES2040847T3 (xx) |
GR (1) | GR3002426T3 (xx) |
HK (1) | HK127793A (xx) |
IE (1) | IE60568B1 (xx) |
NZ (1) | NZ224380A (xx) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01135704A (ja) * | 1987-11-18 | 1989-05-29 | Medical Res Internatl Ltd | 微生物を破壊する表面処理方法 |
US5434182A (en) * | 1987-12-31 | 1995-07-18 | Isaacs; Charles E. | Antibacterial fatty acid compositions |
FI912955A (fi) * | 1990-06-25 | 1991-12-26 | Res Found Mental Hygiene | Antimikroba fettsyrasammansaettningar. |
GB9023701D0 (en) * | 1990-10-31 | 1990-12-12 | Efamol Holdings | Medical treatment |
GB9218064D0 (en) * | 1992-08-25 | 1992-10-14 | Efamol Holdings | Method for the safe intravenous administration of fatty acids |
EP0585057A1 (en) * | 1992-08-25 | 1994-03-02 | Scotia Holdings Plc | Lithium salts of fatty acids for the treatment of viral infections and cancer |
GB9301446D0 (en) * | 1993-01-26 | 1993-03-17 | Scotia Holdings Plc | Internal radiation damage |
GB9304746D0 (en) * | 1993-03-09 | 1993-04-28 | Scotia Holdings Plc | Treatment of viral infections |
AU1067795A (en) * | 1993-11-26 | 1995-06-13 | Karla Lehmann | Use of lithium compounds in the treatment and prevention of alzheimer's disease |
GB9509764D0 (en) * | 1995-05-15 | 1995-07-05 | Tillotts Pharma Ag | Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids |
GB2300807B (en) * | 1995-05-15 | 1999-08-18 | Tillotts Pharma Ag | Oral dosage forms of omega-3 polynunsaturated acids for the treatment of inflammatory bowel disease |
JPH0987176A (ja) * | 1995-09-26 | 1997-03-31 | Shiseido Co Ltd | 糸球体腎炎抑制剤 |
WO1997039759A2 (en) * | 1996-04-24 | 1997-10-30 | Brigham And Women's Hospital | Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder |
DE19629433A1 (de) * | 1996-07-22 | 1998-01-29 | Hoechst Ag | Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier |
GB9621990D0 (en) * | 1996-10-22 | 1996-12-18 | Scotia Pharma Ltd | Use |
US6344482B1 (en) | 1997-04-23 | 2002-02-05 | Andrew L. Stoll | Omega-3 fatty acids in the treatment of bipolar disorder |
US6852870B2 (en) | 1999-03-22 | 2005-02-08 | Andrew Stoll | Omega-3 fatty acids in the treatment of depression |
EP1030560B1 (en) | 1997-10-09 | 2007-09-26 | Emory University | Method and devices for transdermal delivery of lithium |
GB9904895D0 (en) * | 1999-03-03 | 1999-04-28 | Scarista Limited | Regulators of coenzyme-A-independent transacylase as psychotropic drugs |
US6610324B2 (en) | 1999-04-07 | 2003-08-26 | The Mclean Hospital Corporation | Flupirtine in the treatment of fibromyalgia and related conditions |
GB0403247D0 (en) * | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
GB0425658D0 (en) * | 2004-11-22 | 2004-12-22 | Stanford Rook Ltd | Immunotherapeutic agent |
GB201001345D0 (en) * | 2010-01-27 | 2010-03-17 | Equateq Ltd | Process for preparing and purifying fatty acids |
BRPI1000970A2 (pt) * | 2010-04-07 | 2011-11-29 | Fundacao Arnaldo Vieira De Carvalho | composição farmacêutica para o tratamento da doença de alzheimer, processo para sua obtenção e uso |
KR102153143B1 (ko) | 2012-01-06 | 2020-09-08 | 옴테라 파마슈티칼스, 인크. | 유리 산 형태의 오메가-3 다중불포화 지방산의 dpa-농축 조성물 |
KR20150028233A (ko) | 2012-05-07 | 2015-03-13 | 옴테라 파마슈티칼스, 인크. | 스타틴 및 오메가-3 지방산의 조성물 |
GB201216385D0 (en) | 2012-09-13 | 2012-10-31 | Chrysalis Pharma Ag | A pharmaceutical composition |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3639625A (en) * | 1967-07-13 | 1972-02-01 | Lewis Sherwin | Compositions containing lithium succinate |
US4172123A (en) * | 1968-07-19 | 1979-10-23 | Grillo-Werke Aktiengesellschaft | Deodorants for both cosmetic and commercial use |
FR2125219A1 (en) * | 1971-02-19 | 1972-09-29 | Greene Martin | Lithium undecylenate for topical fungal disorders |
FR2244485A1 (en) * | 1973-08-06 | 1975-04-18 | Aries Robert | Lithium dicarboxylic acid salts - in compositions for treatment of psychoses, esp. manic depression |
US4328243A (en) * | 1981-04-07 | 1982-05-04 | Horrobin David F | Manic-depressive illnesses |
US4386072A (en) * | 1981-06-26 | 1983-05-31 | Horrobin David F | Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor |
US4398937A (en) * | 1981-10-06 | 1983-08-16 | The University Of Southern Mississippi | Selective algaecides for control of cyanochloronta |
AU556817B2 (en) * | 1982-02-03 | 1986-11-20 | Efamol Limited | Topical application of a lithium salt and dihomo-alpha- linolenic acid |
GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
US4582709A (en) * | 1985-02-08 | 1986-04-15 | Warner-Lambert Company | Chewable mineral supplement |
GB8601915D0 (en) * | 1986-01-27 | 1986-03-05 | Efamol Ltd | Pharmaceutical compositions |
AU6768587A (en) * | 1987-01-19 | 1988-07-21 | Donnini, Tatiana | Ceramic tile cutter |
-
1988
- 1988-04-20 ES ES88303560T patent/ES2040847T3/es not_active Expired - Lifetime
- 1988-04-20 DE DE8888303560T patent/DE3863678D1/de not_active Expired - Lifetime
- 1988-04-20 EP EP88303560A patent/EP0289204B1/en not_active Expired - Lifetime
- 1988-04-26 CA CA000565045A patent/CA1306944C/en not_active Expired - Lifetime
- 1988-04-26 NZ NZ224380A patent/NZ224380A/en unknown
- 1988-04-26 DK DK198802255A patent/DK173068B1/da not_active IP Right Cessation
- 1988-04-26 JP JP63103715A patent/JP2699083B2/ja not_active Expired - Fee Related
- 1988-04-26 IE IE124488A patent/IE60568B1/en not_active IP Right Cessation
- 1988-04-27 AU AU15361/88A patent/AU618730B2/en not_active Ceased
-
1991
- 1991-08-02 GR GR91401114T patent/GR3002426T3/el unknown
-
1993
- 1993-11-18 HK HK1277/93A patent/HK127793A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK173068B1 (da) | 1999-12-13 |
JP2699083B2 (ja) | 1998-01-19 |
GR3002426T3 (en) | 1992-12-30 |
DK225588A (da) | 1988-10-28 |
IE60568B1 (en) | 1994-07-27 |
NZ224380A (en) | 1991-06-25 |
DK225588D0 (da) | 1988-04-26 |
CA1306944C (en) | 1992-09-01 |
IE881244L (en) | 1988-10-27 |
EP0289204A2 (en) | 1988-11-02 |
DE3863678D1 (de) | 1991-08-22 |
JPS6413021A (en) | 1989-01-17 |
ES2040847T3 (es) | 1996-07-16 |
AU1536188A (en) | 1988-10-27 |
EP0289204A3 (en) | 1989-04-26 |
EP0289204B1 (en) | 1991-07-17 |
AU618730B2 (en) | 1992-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK127793A (en) | Lithium salt-containing pharmaceutical compositions | |
GR3002410T3 (en) | Pharmaceutical compositions | |
HK106191A (en) | Pharmaceutical composition | |
GB8710965D0 (en) | Pharmaceutical compositions | |
GB8826321D0 (en) | Pharmaceutical compositions | |
EG18652A (en) | Pharmaceutical compositions | |
GB8804697D0 (en) | Pharmaceutical compositions | |
GB8810716D0 (en) | Pharmaceutical compositions | |
ZA888391B (en) | Pharmaceutical compositions | |
GB8713091D0 (en) | Pharmaceutical compositions | |
SG113593G (en) | Lithium salt-containing pharmaceutical compositions | |
ZA882947B (en) | Lithium salt-containing pharmaceutical compositions | |
ZA882861B (en) | Pharmaceutical compositions | |
GB8827838D0 (en) | Pharmaceutical compositions | |
ZA885500B (en) | Pharmaceutical compositions | |
GB8713349D0 (en) | Pharmaceutical compositions | |
GB8723187D0 (en) | Pharmaceutical compositions | |
GR871629B (en) | Pharmaceutical compositions | |
IE871141L (en) | Pharmaceutical compositions | |
IE870950L (en) | Pharmaceutical compositions | |
GB8716783D0 (en) | Pharmaceutical compositions | |
IE871692L (en) | Pharmaceutical compositions | |
IE872188L (en) | Pharmaceutical compositions | |
GB8716380D0 (en) | Pharmaceutical compositions | |
GB8700812D0 (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20050420 |